Who
Foresite Capital Management VI LLC
10% owner
Company insider
Files Form 4 as: 10% owner, Alumis.
In numbers
- Trades disclosed
- 14
- Buys
- 4
- Sells
- 0
- Bought
- $10.1M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 17 Nov 2025
- Last trade
- 1 Apr 2026
- Last filed
- 3 Apr 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Apr 2026filed 3 Apr 2026 | ALMS AlumisBiotechnology | SEC FORM 4 Code J | —1,176,470 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | ALMS AlumisBiotechnology | SEC FORM 4 Code J | —1,123,337 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | ALMS AlumisBiotechnology | SEC FORM 4 Code J | —1,123,337 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | ALMS AlumisBiotechnology | SEC FORM 4 Code J | —680,486 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | ALMS AlumisBiotechnology | SEC FORM 4 Code J | —1,176,470 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | ALMS AlumisBiotechnology | SEC FORM 4 Code J | —1,123,337 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | ALMS AlumisBiotechnology | SEC FORM 4 Code J | —1,123,337 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | ALMS AlumisBiotechnology | SEC FORM 4 Code J | —680,486 at $0.00 | filing |
| 8 Jan 2026filed 12 Jan 2026 | ALMS AlumisBiotechnology | SEC FORM 4 Bought | $2.0M117,647 at $17.00 | filing |
| 8 Jan 2026filed 12 Jan 2026 | ALMS AlumisBiotechnology | SEC FORM 4 Bought | $5.0M294,117 at $17.00 | filing |
| 19 Nov 2025filed 19 Nov 2025 | ALMS AlumisBiotechnology | SEC FORM 4 Bought | $1.2M190,500 at $6.56 | filing |
| 18 Nov 2025filed 19 Nov 2025 | ALMS AlumisBiotechnology | SEC FORM 4 Bought | $727K117,374 at $6.19 | filing |
| 17 Nov 2025filed 19 Nov 2025 | ALMS AlumisBiotechnology | SEC FORM 4 Bought | $280K50,000 at $5.60 | filing |
| 17 Nov 2025filed 19 Nov 2025 | ALMS AlumisBiotechnology | SEC FORM 4 Bought | $839K150,000 at $5.59 | filing |
News
WAVE Life Sciences (NASDAQ:WVE) and Alumis (NASDAQ:ALMS) Head to Head ComparisonALMS · dailypolitical.com · 18 Oct 2026Alumis Inc.: Alumis Announces New Phase 3 Data Demonstrating Envudeucitinib Rapidly and Durably Improved Psoriasis Burden Across Scalp, Itch, and Quality of Life MeasuresALMS · finanznachrichten.de · 9 Oct 2026
0 headlines in the last 90 days name Foresite Capital Management VI LLC; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.